Prashant Kumar Nageshwar MD

Attending Physician - Dana-Farber Cancer Institute

75 Francis St# BrighamBoston, MA 02115
Phone+1 617-632-3382
Fax+1 617-582-9250

Dr. Nageshwar is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nageshwar's full profile Already have an account?

Summary

Dr. Prashant Nageshwar is an Oncologist located in Boston, MA. He completed his fellowship in Hematology and Medical Oncology at the University at Buffalo and an Advanced Fellowship in Leukemia and Bone Marrow Transplant Program at The University of British Columbia- British Columbia Cancer Agency. Additionally, he held a residency in Internal Medicine at Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital. He currently works as an Attending Physician at Dana-Farber Cancer Institute. His areas of expertise include amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and bone marrow transplantation. Dr. Nageshwar has contributed to a number of publications in his field.

Education & Training

The University of British Columbia- British Columbia Cancer AgencyAdvanced Fellowship, Leukemia/ Bone Marrow Transplant Program of BC, 2014 - 2015
University at BuffaloFellowship, Hematology and Medical Oncology, 2011 - 2013
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2008 - 2011
OtherClass of 2006, MD
University of DelhiMD, Medicine, 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2015 - 2028
RI State Medical License 2026 - 2028
MI State Medical License 2020 - 2027
NY State Medical License 2013 - 2027
WI State Medical License 2025 - 2027
PA State Medical License 2023 - 2026
LA State Medical License 2022 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
British Columbia Cancer AgencyPostgraduate Program in Leukemia and Bone Marrow Transplant

Publications & Presentations

PubMed

No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.
H Moses Murdock, Haesook T Kim, Katie Maurer, Amar Kelkar, Roman M Shapiro
Blood Advances. 2026-02-24
14 citations
Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
Natasha Kekre, Haesook T Kim, Julia Hofer, Vincent T Ho, John Koreth
Bone Marrow Transplantation. 2021-05-01
1 citations
Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease (Bone Marrow Transplantation, (...
Natasha Kekre, Haesook T. Kim, Julia Hofer, Vincent T. Ho, John Koreth
Bone Marrow Transplantation. 2021-05-01